Suprachoroidal drug infusion for the treatment of severe subfoveal hard exudates

Retina

Volumn 32, Issue 4, 2012, Pages 776-784

  Rizzo, Stanislao ^a   Ebert, Federica Genovesi ^a   Di Bartolo, Emanuele ^a   Barca, Francesco ^a   Cresti, Federica ^a   Augustin, Constanze ^b   Augustin, Albert ^b  

^a UNIVERSITY OF PISA   (Italy)

^b Hospital Karlsruhe   (Germany)

Author keywords

hard subfoveal exudates; pars plana vitrectomy; suprachoroidal infusion

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CAPILLARY LEAK SYNDROME; CATHETER; CENTRAL RETINA VEIN OCCLUSION; CHOROID; CLINICAL ARTICLE; CLINICAL TRIAL; DIABETIC MACULAR EDEMA; DISEASE SEVERITY; DRUG ADMINISTRATION ROUTE; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; MALE; MICROCATHETER; OPTICAL COHERENCE TOMOGRAPHY; PILOT STUDY; PROGNOSIS; PROSPECTIVE STUDY; RETINA EXUDATE; RISK ASSESSMENT; SUBFOVEAL HARD EXUDATE; SUPRACHOROIDAL DRUG INFUSION; SUPRACHOROIDAL SPACE; THICKNESS; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; CATHETERIZATION; DIABETIC RETINOPATHY; EXUDATES AND TRANSUDATES; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MACULAR EDEMA; MALE; MICROSURGERY; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; RETINAL VEIN OCCLUSION; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY;

EID: 84859100882     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3182278b0e     Document Type: Article

References (36)

1. Bresnick GH. Diabetic maculopathy: acritical review highlighting diffuse macular edema. Ophthalmology 1983; 90:1301-1317. (Pubitemid 14200813)
2. Otani T, Kishi S. Tomographic findings of foveal hard exudates in diabetic macular edema. Am J Ophthalmol 2001;131:50-54. (Pubitemid 32037008)
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329: 977-986.
4. The United Kingdom Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853.
5. Do DV, Shah SM, Sung JU, et al. Persistent diabetic macular edema is associated with elevated hemoglobin A1C. Am J Ophthalmol 2005;139:620-623.
6. Deák GG, Bolz M, Kriechbaum K, et al. Effect of retinal photocoagulation on intraretinal lipid exudates in diabetic macular edema documented by optical coherence tomography. Ophthalmology 2010;117:773-779.
7. Guyot-Argenton C, El Maftouhi A. Failure of photocoagulation therapy for diabetic macular edema. J Fr Ophtalmol 2004; 27(6 pt 1):597-603. (Pubitemid 38998563)
8. Ciardella AP, Klancnik J, SchiffW, et al. Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study. Br J Ophthalmol 2004;88:1131-1136. (Pubitemid 39141371)
9. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema.Ophthalmology 2002;109:920-927. (Pubitemid 34465226)
10. Avci R, Kaderli B. Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates. Graefes Arch Clin Exp Ophthalmol 2006;244:28-35. (Pubitemid 43013179)
11. Dahr SS, Cusick M, Rodriguez-Coleman H. Intravitreal antivascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina. Retina 2007;27:150-188.
12. Olsen TW, Feng X, Wabner K, et al. Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment. Am J Ophthalmol 2006;142:777-787.
13. Zhu Q, Ziemssen F, Henke-Fahle S, et al. Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization. Ophthalmology 2008;115:1750-1755.
14. Beer PM, Bakri SJ, Singh RJ, et al. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 2003;110: 681-686. (Pubitemid 36520063)
15. Angulo Bocco MC, Glacet-Bernard A, Zourdani A, et al. Intravitreous injection: retrospective study of 2028 injections and their side effects. J Fr Ophtalmol 2008;31:693-698.
16. Wu L, Arevalo JF, Berrocal MH, et al. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months. Retina 2010;30:1002-1011.
17. Yang CM. Surgical treatment for severe diabetic macular edema with massive hard exudates. Retina 2000;20:121-125. (Pubitemid 30395705)
18. Takagi H, Otani A, Kiryu J, Ogura Y. New surgical approach for removing massive foveal hard exudates in diabetic macular edema. Ophthalmology 1999;106:249-256.
19. Sakuraba T, Suzuki Y, Mizutani H, Nakazawa M. Visual improvement after removal of submacular exudates in patients with diabetic maculopathy. Ophthalmic Surg Lasers 2000;31: 287-291. (Pubitemid 30603045)
20. Takaya K, Suzuki Y, Mizutani H, Long-term results of vitrectomy for removal of submacular hard exudates in patients with diabetic maculopathy. Retina 2004;24:23-29. (Pubitemid 38240837)
21. Naito T, Matsushita S, Sato H, et al. Results of submacular surgery to remove diabetic submacular hard exudates. J Med Invest 2008; 55:211-215.
22. Kim SH, Galbán CJ, Lutz RJ, et al. Assessment of subconjunctival and intrascleral drug delivery to the posterior segment using dynamic contrast-enhanced magnetic resonance imaging. Invest Ophthalmol Vis Sci 2007;48:808-814. (Pubitemid 351260716)
23. Entezari M, Ahmadieh H, Dehghan MH, et al. Posterior sub- Tenon triamcinolone for refractory diabetic macular edema: a randomized clinical trial. Eur J Ophthalmol 2005;15: 746-750. (Pubitemid 43074701)
24. Ip MS, Scott IU, VanVeldhuisen PC, et al SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol 2009;127:1101-1114.
25. Kinge B, Stordahl PB, Forsaa V, et al. Efficacy of ranibizumab in patients with macular edema secondary to central retinal vein occlusion: results from the sham-controlled ROCC study. Am J Ophthalmol 2010;150:310-314.
26. Campochiaro PA, Hafiz G, Channa R, et al. Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes. Ophthalmology 2010;117:2387-2394.
27. Rizzo S, Augustin AJ, Tetz M, et al. Suprachoroidal drug delivery for the treatment of advanced, exudative age-related macular degeneration. Invest Ophthalmol Vis Sci 2010;51: e-Abstract:256. ARVO.
28. Hamilton AMP, Ulbig MW, Polkinghorne P. Management of Diabetic Retinopathy. London: BMJ Publishing Group; 1996: 115-128.
29. Sigurdsson R, Begg IS. Organised macular plaques inexudative diabetic maculopathy. Br J Ophthalmol 1980;64:392-397. (Pubitemid 10056138)
30. Toussaint D, Cogan DG, Kuwabara T. Extravascular lesions of diabetic retinopathy. Arch Ophthalmol 1962;67:42-47.
31. Murata T, Ishibashi T, Inomata H. Immunohistochemical detection of extravasated fibrinogen (fibrin) in human diabetic retina. Graefes Arch Clin Exp Ophthalmol 1992;30:428-431.
32. Vinores SA, Gadegbeku C, Campochiaro PA, Green WR. Immunohistochemical localization of blood-retinal barrier breakdown in human diabetes. Am J Pathol 1989;134: 231-235. (Pubitemid 19063877)
33. Early Treatment of Diabetic Retinopathy Study Group. Photocoagulation for diabetic macular edema. Early treatment of diabetic retinopathy study report number 1. Arch Ophthalmol 1985;103:1796- 1806.
34. Ferris FL, Patz A. Macular edema: acomplication of diabetic retinopathy. Surv Ophthalmol 1984;28:452-461. (Pubitemid 14076504)
35. Fong DS, Segal PP, Myers F, et al. Subretinal fibrosis indiabetic macular edema. ETDRS report no. 23. Arch Ophthalmol 1997;115:873-877.
36. Avci R, Inan ÜÜ, Kaderli B. Long-term results of excision of plaque-like foveal hard exudates in patients with chronic diabetic macular oedema. Eye 2008;22:1099-1104.